This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/uk/515145-uk-revaccinating-covid-variants-johnson/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| UK needs to ‘get used to idea of re-vaccinating’ later this year amid new British Covid-19 variants, says Johnson | UK needs to ‘get used to idea of re-vaccinating’ later this year amid new British Covid-19 variants, says Johnson |
| (about 1 month later) | |
| The UK will need to re-vaccinate people against Covid-19 later this year because of new variants of the virus that are potentially more resistant to jabs, Prime Minister Boris Johnson has warned. | The UK will need to re-vaccinate people against Covid-19 later this year because of new variants of the virus that are potentially more resistant to jabs, Prime Minister Boris Johnson has warned. |
| “We’re going to have to get used to the idea of vaccinating and then re-vaccinating in the autumn as we come to face these new variants,” Johnson told MPs in the House of Commons. | “We’re going to have to get used to the idea of vaccinating and then re-vaccinating in the autumn as we come to face these new variants,” Johnson told MPs in the House of Commons. |
| An MP asked Johnson about the ability of the UK’s vaccine supply chain to “keep pace” with the virus as it mutates. | An MP asked Johnson about the ability of the UK’s vaccine supply chain to “keep pace” with the virus as it mutates. |
| Johnson said the UK’s recent deal for 50 million doses of the Covid-19 vaccine being developed by German biotech firm CureVac would help the country respond “at scale” to new variants. | Johnson said the UK’s recent deal for 50 million doses of the Covid-19 vaccine being developed by German biotech firm CureVac would help the country respond “at scale” to new variants. |
| The deal comes after the government’s New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) said on Tuesday it had detected two new home-grown variants of the virus in the UK. | The deal comes after the government’s New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) said on Tuesday it had detected two new home-grown variants of the virus in the UK. |
| One of the two new strains is a mutated form of the original UK variant – B117 – and has been declared a “variant of concern” after a total of 21 cases had been discovered across Bristol, Manchester and other areas. | One of the two new strains is a mutated form of the original UK variant – B117 – and has been declared a “variant of concern” after a total of 21 cases had been discovered across Bristol, Manchester and other areas. |
| Some 42 new cases of the other new variant, which is “under investigation,” have been recorded across Liverpool, Warrington and Lancashire. | Some 42 new cases of the other new variant, which is “under investigation,” have been recorded across Liverpool, Warrington and Lancashire. |
| Both new variants could prove resistant to jabs because they contain the E484K mutation in the spike protein, which may limit vaccine efficacy, according to the British Medical Journal. | Both new variants could prove resistant to jabs because they contain the E484K mutation in the spike protein, which may limit vaccine efficacy, according to the British Medical Journal. |
| More than 12.6 million people in the UK have now received their first dose of a Covid-19 vaccine, while 500,000 people have had their second dose. | More than 12.6 million people in the UK have now received their first dose of a Covid-19 vaccine, while 500,000 people have had their second dose. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |